Clinical Experience with the Baerveldt 250-mm2 Glaucoma Implant

The Ahmed Glaucoma Valve in Patients With and Without Neovascular Glaucoma

“…Although the definition of success and types of implants vary in other studies, results from noncomparative studies using other glaucoma drainage implants have shown similar success rates to the rates reported in this study. [4][5][6][7][8][9] WuDunn et al did a subgroup analysis of 34 eyes with neovascular glaucoma in a group of 108 eyes treated with the Baerveldt 250-mm 2 implant, and found neovascular glaucoma patients significantly more likely to fail owing to elevated IOP. 8 Although a direct comparison of different implant types is not possible in this study, a retrospective review found no significant difference in mean IOP or cumulative probability of success after Ahmed Glaucoma Valve or Molteno implant in 65 eyes with neovascular glaucoma.…”

“…1,2 The initial description of the use of glaucoma drainage implants in neovascular glaucoma was by Molteno et al, 3 who described the technique for implantation and IOP results in 12 patients with an average of 13 months follow-up. Noncomparative retrospective studies have described results in patients with neovascular glaucoma after the Molteno implant, 4,5 the Krupin implant, 6,7 and the Baerveldt implant, 8,9 with no control group for comparison. The purpose of this study was to compare the outcomes of glaucoma drainage implant surgery using the Ahmed Glaucoma Valve in controls and in patients with neovascular glaucoma.…”

Capsule excision and Ologen™ implantation for revision after glaucoma drainage device surgery

“…score Molteno (Molteno Ophthalmic Ltd, New Zealand) devices. As described above, surgical success rates ranged from 60 to 90% over a period of 12-27 months postoperatively, almost regardless of the type of implant used [2][3][4][5].…”

“…Furthermore, GDDs offer a better chance of successful glaucoma control in the first 2 years of life in infantile glaucoma compared to trabeculectomy with MMC [1]. Surgical success rates of glaucoma drainage devices range between 60 and 90% in a period of 12-27 months after surgery, with a yearly failure rate of 10% in subsequent years almost regardless of the type of implant used [2][3][4][5].…”

Modern concepts in antiglaucomatous implant surgery

“…Systematic review of reliable literature on glaucoma drainage devices has demonstrated that the overall surgical success rates range between 60-90% in a period of 12-27 months after surgery, with a yearly failure rate of 10 percent in subsequent years, almost regardless of the type of implant used and even in combination with simultaneous cataract surgery [16,31,37,81,89]. Even the rates of major complications such as hypotony, suprachoroidal hemorrhage, and decrease of visual acuity were comparable for the different devices, although a higher percentage of diplopia occurred after use of the larger Baerveldt implants.…”